Pharmacology & ToxicologybioRxivPreprint
Population Pharmacokinetics Study of Morinidazole in Patients with Moderate Hepatic Impairment
Yue Kang, Fengyan Xu, Kun Wang…·Yingyuan Zhang
This study builds a population pharmacokinetic model of morinidazole in patients with hepatic impairment and provides dosage adjustment strategies based on covariates like disease status and weight.
DOI 10.1101/312728